FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet

Kernel’s Brain-Imag­ing Hel­met Approved For Clin­i­cal Tri­al On Patients Using Ket­a­mine (Forbes): The U.S. Food and Drug Admin­is­tra­tion has approved a clin­i­cal tri­al using a neu­roimag­ing hel­met made by Los Ange­les-based Ker­nel to track what hap­pens in the brain when a human takes a psy­che­del­ic dose of ketamine.

Read More

Neuroimaging, big data and mental health: A survey of the land

Men­tal and degen­er­a­tive dis­or­ders are among the most cost­ly and com­mon caus­es of dis­abil­i­ty in soci­ety today. Because the brain is the most com­plex organ in the human body, diag­nos­ing and treat­ing prob­lems when things go wrong pos­es enor­mous chal­lenges. Even before the 1990s was des­ig­nat­ed the Decade of the Brain, the poten­tial of neuroimaging—the…

Read More

Update: The placebo effect works even when people know they are taking a placebo

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing 14 research find­ings, resources and tips for brain health … and start­ing with this fas­ci­nat­ing study: #1. Wow. The place­bo effect works even when peo­ple know they are tak­ing a place­bo #2. Beat­ing Alzheimer’s Dis­ease will require a com­bined physical/ men­tal approach: From the ten fac­tors found…

Read More

Flexibility is good except when it isn’t: Study finds how scientists can reach different conclusions analyzing the same brain scans

Neu­roimag­ing: Many Ana­lysts, Dif­fer­ing Results (Dana Foun­da­tion): For decades, both the research and med­ical com­mu­ni­ties have relied on neu­roimag­ing tools like func­tion­al mag­net­ic res­o­nance imag­ing (fMRI) to give them a win­dow into the liv­ing human brain. Such scans have pro­vid­ed unprece­dent­ed insights into the brain’s struc­ture and func­tion – and the field, as a whole,…

Read More